{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:34:55Z","timestamp":1791614095760,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/02203-7"],"award-info":[{"award-number":["2017\/02203-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jgar.2021.03.018","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T05:53:33Z","timestamp":1617256413000},"page":"199-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Trends towards lower azole susceptibility among 200 Candida tropicalis bloodstream isolates from Brazilian medical centres"],"prefix":"10.1016","volume":"25","author":[{"given":"Larissa M.","family":"Favarello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Queiroz-Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro J.","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa C.T.","family":"Sukiennik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"da Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analy S.A.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo L.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2021.03.018_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jof3020024","article-title":"Revisiting species distribution and antifungal susceptibility of Candida bloodstream isolates from Latin American medical centers","volume":"3","author":"da Matta","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jgar.2021.03.018_bib0002","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","article-title":"Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study","volume":"21","author":"Tan","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2021.03.018_bib0003","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jinf.2015.05.009","article-title":"Candida tropicalis bloodstream infection: incidence, risk factors and outcome in a population-based surveillance","volume":"71","author":"Fernandez-Ruiz","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2021.03.018_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6808a1","article-title":"Population-based active surveillance for culture-confirmed candidemia\u2014four sites, United States, 2012\u20132016","volume":"68","author":"Toda","year":"2019","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.jgar.2021.03.018_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diagmicrobio.2006.11.009","article-title":"Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals","volume":"58","author":"Nucci","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2021.03.018_bib0006","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2217\/fmb-2018-0059","article-title":"Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside","volume":"13","author":"Beardsley","year":"2018","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jgar.2021.03.018_bib0007","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/13693786.2012.698024","article-title":"Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals","volume":"51","author":"Colombo","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2021.03.018_bib0008","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00134-014-3400-y","article-title":"Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period","volume":"40","author":"Colombo","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2021.03.018_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146909","article-title":"Epidemiology and microbiologic characterization of nosocomial candidemia from a Brazilian national surveillance program","volume":"11","author":"Doi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2021.03.018_bib0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmi.2014.11.009","article-title":"Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections","volume":"21","author":"Ghosh","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2021.03.018_bib0011","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","year":"2017"},{"key":"10.1016\/j.jgar.2021.03.018_bib0012","series-title":"Performance standards for antifungal susceptibility testing of yeasts","year":"2017"},{"key":"10.1016\/j.jgar.2021.03.018_bib0013","first-page":"91","article-title":"Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study [in Spanish]","volume":"28","author":"Peman","year":"2011","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.jgar.2021.03.018_bib0014","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-016-2841-3","article-title":"Epidemiology and reporting of candidaemia in Belgium: a multi-centre study","volume":"36","author":"Trouve","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2021.03.018_bib0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.myc.2016.11.001","article-title":"ERG11 mutations are associated with high-level azole resistance in clinical Candida tropicalis isolates, a Singapore study","volume":"58","author":"Chew","year":"2017","journal-title":"Mycoscience"},{"key":"10.1016\/j.jgar.2021.03.018_bib0016","doi-asserted-by":"crossref","first-page":"e00577","DOI":"10.1128\/JCM.00577-18","article-title":"Five-year national surveillance of invasive candidiasis: species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study","volume":"56","author":"Xiao","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2021.03.018_bib0017","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/jac\/dkw091","article-title":"Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa","volume":"71","author":"Govender","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.03.018_bib0018","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jac\/dkx047","article-title":"Changing epidemiology of candidaemia in Australia","volume":"72","author":"Chapman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.03.018_bib0019","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/mmy\/myx077","article-title":"Breakthrough candidemia after the introduction of broad spectrum antifungal agents: a 5-year retrospective study","volume":"56","author":"Breda","year":"2018","journal-title":"Med Mycol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:57:12Z","timestamp":1761991032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716521000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":19,"alternative-id":["S2213716521000849"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2021.03.018","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends towards lower azole susceptibility among 200 Candida tropicalis bloodstream isolates from Brazilian medical centres","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2021.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}